Clinical Effectiveness of Influenza Vaccination in Manitoba

JAMA: The Journal of the American Medical Association

Volumn 270, Issue 16, 1993, Pages 1956-1961

  Fedson, David S ^a   Kaiser, Donald L ^a   Wajda, Andra ^b   Nicol, J Patrick ^b   Hammond, Gregory W ^b   Roos, Leslie L ^c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Departments of Medical Microbiology   (United States)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; CONTROLLED STUDY; DRUG EFFICACY; EPIDEMIC; FEMALE; HEALTH STATISTICS; HOSPITALIZATION; HUMAN; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS;

AGED; CASE-CONTROL STUDIES; DISEASE OUTBREAKS; FEMALE; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA A VIRUS, HUMAN; INFLUENZA VACCINE; MALE; MANITOBA; MIDDLE AGE; MORBIDITY; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027385470     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1993.03510160074032     Document Type: Article

References (46)

1. Barker WH, Mullooly JP. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol. 1980;112:798-811.
2. Alling DW, Blackwelder WC, Stuart-Harris CH. A study of excess mortality during influenza epidemics in the United States, 1968-1976. Am J Epidemiol. 1981;113:30-43.
3. Barker WH, Mullooly JP. Underestimation of the role of pneumonia and influenza in causing excess mortality. Am J Public Health. 1981;71:643-645.
4. Glezen WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev. 1982;2:25-44.
5. Barker WH, Mullooly JP. Pneumonia and influenza deaths during epidemics: implications for prevention. Arch Intern Med. 1982;142:85-89.
6. Blackwelder WC, Alling DW, Stuart-Harris CH. Association of excess mortality from chronic nonspecific lung disease with epidemics of influenza. Am Rev Respir Dis. 1982;125:5111-5116.
7. Liu K, Kendal AP. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am J Public Health. 1987;77: 712-716.
8. Perrotta DM, Decker M, Glezen WP. Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza. Am J Epidemiol. 1985; 122:468-476.
9. Barker WH. Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78. Am J Public Health. 1986;76:761-765.
10. Glezen WP, Decker M, Perrotta DM. Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981. Am Rev Respir Dis. 1987;136:550-555.
11. Centers for Disease Control. Prevention and control of influenza. MMWR Morb Mortal Wkly Rep. 1992;41(RR-9):1-17.
12. La Montagne JR, Noble GR, Quinnan GV, et al. Summary of clinical trials of inactivated influenza vaccine—1978. Rev Infect Dis. 1983;5:723-736.
13. Stuart WH, Dull HB, Newton LH, McQueen JL, Schiff ER. Evaluation of monovalent influenza vaccine in a retirement community during the epidemic of 1965-1966. JAMA. 1969;209:232-238.
14. Schoenbaum SC, Mostow SR, Dowdle WR, Coleman MT, Kaye HS. Studies with inactivated influenza vaccines purified by zonal centrifugation, 2: efficacy. Bull World Health Organ. 1969;41:531-535.
15. Edmondson WP, Rothenberg R, White PW, Gwaltney JM Jr. A comparison of subcutaneous, nasal and combined influenza vaccination, II: protection against natural challenge. Am J Epidemiol. 1971;93:480-486.
16. Patriarca PA, Weber JA, Parker RA, et al. Efficacy of influenza vaccine in nursing homes: reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA. 1985;253:1136-1139.
17. Saah AJ, Neufeld R, Rodstein M, et al. Influenza vaccine and pneumonia mortality in a nursing home population. Arch Intern Med. 1986;146:2353-2557.
18. Arden NH, Patriarca PA, Kendal AP. Experiences in the use and efficacy of inactivated influenza vaccine in nursing homes. In: Kendal AP, Patriarca PA, eds. Options for the Control of Influenza. New York, NY: Alan R Liss Inc; 1986:155-168.
19. Gross PA, Quinnan GV, Rodstein M, et al. Association of influenza immunization with reduction in mortality in an elderly population: a prospective study. Arch Intern Med. 1988;148:562-565.
20. Barker WH, Mullooly JP. Influenza vaccination of elderly persons: reduction in pneumonia hospitalizations and deaths. JAMA. 1980;244: 2547-2549.
21. Barker WH, Mullooly JP. Effectiveness of inactivated influenza vaccine among noninstitutionalized elderly persons. In: Kendal AP, Patriarca PA, eds. Options for the Control of Influenza. New York, NY: Alan R Liss Inc; 1986:169-182.
22. Strassburg MA, Greenland S, Sorvilo FJ, et al. Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports. Vaccine. 1991;4:38-44.
23. Smith PG, Rodrigues LC, Fine PEM. Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. Int J Epidemiol. 1984;13:87-93.
24. Comstock GW. Vaccine evaluation by case-control or prospective studies. Am J Epidemiol. 1990; 131:205-207.
25. Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med. 1991;325: 1453-1458.
26. Foster DA, Talsma A, Furumoto-Dawson A, et al. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am J Epidemiol. 1992;136:296-307.
27. Roos LL Jr, Nicol JP, Cageorge SM. Using administrative data for longitudinal research: comparisons with primary data collection. J Chronic Dis. 1987;40:41-49.
28. Roos NP. Using administrative data from Manitoba, Canada to study treatment outcomes: developing control groups and adjusting for case severity. Soc Sci Med. 1989;28:109-113.
29. Roos LL, Roos NP, Fisher ES, Bubolz TA. Strengths and weaknesses of health insurance data systems for assessing outcomes. In: Gelijns AC, ed. Medical Information at the Crossroads, I: Modern Methods of Clinical Investigation. Washington, DC: National Academy Press; 1990:47-67.
30. Roos LL, Sharp SM, Cohen MM. Comparing clinical information with claims data: some similarities and differences. J Clin Epidemiol. 1991;44: 881-888.
31. Roos LL, Wajda A, Nicol JP, Roberts J. Record linkage: an overview. In: Grady ML, ed. Medical Effectiveness Research Data Methods. Rockville, Md: Agency for Health Care Policy and Research; June 1992:119-129. Publication 92-0056.
32. Roos LL, Mustard CA, Nicol JP, et al. Registries and administrative data: organization and accuracy. Med Care. 1993;31:201-212.
33. Fedson DS, Wajda A, Nicol JP, Roos LL. Disparity between influenza vaccination rates and risks for influenza-associated hospital discharge and death in Manitoba in 1982-1983. Ann Intern Med. 1992; 116:550-555.
34. Division of Quality Control Management, American Hospital Association. International Classification of Diseases, Ninth Revision, Clinical Modification. Chicago, Ill: American Hospital Publishing Inc; 1989.
35. SAS Institute Inc. SUGI Supplemental Library User's Guide, Version 5. Cary, NC: SAS Institute Inc; 1986:307-328.
36. Cohen MM. Using administrative data for case-control studies: the case of the Papanicolaou smear. Ann Epidemiol. 1993;3:93-98.
37. Saitz EW. Pneumococcal pneumonia: a misleading diagnosis for audit studies. JAMA. 1978;239: 2372.
38. Marrie TJ, Durant H, Sealy E. Pneumonia— the quality of medical records data. Med Care. 1987; 25:20-24.
39. Mazumdar S, Colbus DS, Townsend MC. Validation of hospital discharge diagnosis data for chronic obstructive pulmonary disease and other allied conditions. Am J Public Health. 1986;76:803-805.
40. Institute of Medicine. Reliability of National Hospital Discharge Survey Data. Washington, DC: National Academy Press; 1980.
41. Romano PS, Luft HS. Getting the most out of messy data: problems and approaches for dealing with large administrative data sets. In: Grady ML, ed. Medical Effectiveness Research Data Methods. Rockville, Md: Agency for Health Care Policy and Research; June 1992:57-75. Publication 92-0056.
42. Iezzoni LI. Risk adjustment for medical outcome studies. In: Grady ML, ed. Medical Effectiveness Research Data Methods. Rockville, Md: Agency for Health Care Policy and Research; June 1992:83-97. Publication 92-0056.
43. Iezzoni LI, Foley SM, Daley J, Hughes J, Fisher ES, Heeren T. Comorbidities, complications, and coding bias. JAMA. 1992;267:2197-2203.
44. Bainton D, Jones GR, Hole D. Influenza and ischemic heart disease—a possible trigger for acute myocardial infarction. Int J Epidemiol. 1978;7:231-239.
45. Health Care Financing Administration. Program Memorandum: Intermediaries/Carriers. Washington, DC: Dept of Health and Human Services; July 1993. Transmittal No. AB-93-3.
46. Ghendon Y. Influenza surveillance. Bull World Health Organ. 1991;69:509-515.